Edition:
United States

Holy Stone Healthcare Co Ltd (4194.TWO)

4194.TWO on Gre Tai Securities Market of Chinese Taipei

17.25TWD
26 May 2017
Change (% chg)

NT$-0.05 (-0.29%)
Prev Close
NT$17.30
Open
NT$17.35
Day's High
NT$17.35
Day's Low
NT$17.25
Volume
10,000
Avg. Vol
19,123
52-wk High
NT$33.00
52-wk Low
NT$15.00

Latest Key Developments (Source: Significant Developments)

Holy Stone Healthcare completes issuing 7 mln new shares for T$245 mln
Thursday, 26 May 2016 05:35am EDT 

Holy Stone Healthcare <4194.TWO>: Says it completed issuing 7 million new shares at T$35 per share with amount of T$245 million on May 26 .Says new share issue record date May 26.  Full Article

Holy Stone Healthcare prices new shares
Tuesday, 29 Mar 2016 06:12am EDT 

Holy Stone Healthcare Co., Ltd:Prices the 7 mln new shares at T$35 per share.Subscription record date May 5.Last date before book closure April 30.Book closure period from May 1 to May 5.Payment period from May 11 to May 18.  Full Article

Holy Stone Healthcare to issue new shares
Friday, 26 Feb 2016 02:11am EST 

Holy Stone Healthcare Co., Ltd:To issue 6,125,000 ~ 8,166,667 new shares of its common stock.New shares with par value of T$10 per share and issue price at T$30 ~ T$40 per share.10 pct of the new shares to be offered to the company's employees.Remaining 90 pct to be offered to the existing shareholders, who are eligible to purchase 101.07 ~ 134.76 shares for every 1,000 shares they hold.Proceeds to be used to enrich operating funds.  Full Article

Holy Stone Healthcare announces no dividend payment for 2015
Thursday, 28 Jan 2016 10:16pm EST 

Holy Stone Healthcare Co., Ltd:To pay no dividend to shareholders for 2015.  Full Article

Holy Stone Healthcare gets approval to begin phase two A clinical trial from Agenzia Italiana del Farmaco
Sunday, 8 Nov 2015 07:55pm EST 

Holy Stone Healthcare Co., Ltd:Got approval from Agenzia Italiana del Farmaco to begin phase two A clinical trial of its new drug IBD98-M, which is an anti-inflammatory for inflammatory bowel disease.  Full Article

More From Around the Web

No consensus analysis data available.